BioCryst Pharmaceuticals
BCRX
BCRX
191 hedge funds and large institutions have $1.06B invested in BioCryst Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 57 increasing their positions, 71 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
9.22% less ownership
Funds ownership: 68.29% → 59.07% (-9.2%)
20% less repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 71
Holders
191
Holding in Top 10
3
Calls
$37.2M
Puts
$23.2M
Top Buyers
| 1 | +$49.7M | |
| 2 | +$30.8M | |
| 3 | +$19M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$14.2M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$9.48M |
Top Sellers
| 1 | -$57.8M | |
| 2 | -$38.1M | |
| 3 | -$32.9M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$24.1M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$19.7M |